Important regulatory news last week included French pharma major Sanofi gaining approval from the US Food and Drug ...

Mpox has proven to be a major public threat since its resurgence globally during the COVID years. On August 14, the World ...

Opioid Use Disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, ...

Spain is moving forward with a framework for medical cannabis usage after delays due to a general election. The draft ...

GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

Bristol Myers Squibb has received FDA approval for Opdivo (nivolumab) combined with chemotherapy as a perioperative treatment ...

The US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC ...

Singapore’s Agency for Science, Technology and Research (A*STAR) and US biotech incubator Flagship Pioneering have agree to ...

Trevi Therapeutics has achieved key milestones in its clinical programs for Haduvio (nalbuphine), a treatment targeting ...

Kurma Partners has raised €140 million ($154 million) in the first closing of its Biofund IV, with a target of €250 million ...

Aspire Pharma, a UK-based niche generics firm, has acquired all assets from Canute Pharma, expanding its product range and ...

Sirnaomics has entered a subscription agreement with biotech specialist Poon Hung Fai, who will acquire over 17.5 million ...